PDT Partners, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$179,293
-43.3%
28,779
-38.9%
0.03%
-39.6%
Q3 2022$316,000
-64.0%
47,138
-65.8%
0.05%
-37.7%
Q2 2022$877,000
+8.4%
137,873
-20.9%
0.08%
+10.0%
Q1 2022$809,000
-32.8%
174,315
-27.6%
0.07%
-23.9%
Q4 2021$1,204,000
-17.3%
240,835
+99.3%
0.09%
-12.4%
Q3 2021$1,456,000
-34.1%
120,828
+15.7%
0.10%
-28.1%
Q2 2021$2,208,000
+368.8%
104,400
+522.2%
0.15%
+329.4%
Q1 2021$471,000
-90.0%
16,778
-81.8%
0.03%
-89.4%
Q2 2020$4,731,000
+44.9%
92,200
-11.0%
0.32%
+24.3%
Q1 2020$3,265,000
-21.1%
103,567
+49.2%
0.26%
+1.6%
Q4 2019$4,138,000
+75.6%
69,400
+7.9%
0.26%
+82.1%
Q3 2019$2,357,000
-21.2%
64,306
-0.1%
0.14%
-20.9%
Q2 2019$2,993,000
-73.1%
64,339
-79.6%
0.18%
-69.6%
Q1 2017$11,126,000
+1879.7%
315,100
+601.8%
0.58%
+1475.7%
Q4 2016$562,000
-11.4%
44,900
-2.0%
0.04%0.0%
Q3 2016$634,00045,8000.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$99,609,00022.32%
Bellevue Group AG 5,465,715$203,160,0002.81%
Rhenman & Partners Asset Management AB 455,000$16,912,0001.50%
Endurant Capital Management LP 135,901$5,051,0001.49%
Boxer Capital, LLC 975,000$36,241,0001.25%
DCF Advisers, LLC 56,500$2,100,0001.07%
Pentwater Capital Management LP 2,169,022$80,623,0001.04%
Nicholas Investment Partners, LP 235,855$8,767,0000.95%
Amia Capital LLP 20,464$761,0000.88%
HAMILTON LANE ADVISORS LLC 46,181$1,717,0000.83%
View complete list of ESPERION THERAPEUTICS INC NE shareholders